Central pathology review in muiticenter trials and studies

Cancer

Volumn 115, Issue 9, 2009, Pages 1977-1983

  Vujanić, Gordan M ^a   Sandstedt, Bengt ^b   Kelsey, Anna ^c   Sebire, Neil J ^d  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c ROYAL MANCHESTER CHILDREN S HOSPITAL   (United Kingdom)

^d GREAT ORMOND STREET HOSPITAL   (United Kingdom)

Author keywords

Central pathology review; Renal tumors; Risk stratification; Tumor trials

Indexed keywords

ARTICLE; CANCER DIAGNOSIS; CANCER STAGING; CHILDHOOD CANCER; CLINICAL TRIAL; HUMAN; KIDNEY TUMOR; MEDICAL SOCIETY; MULTICENTER STUDY; NEPHROBLASTOMA; PATHOLOGIST; PATHOLOGY; PHYSICIAN; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TIME; UNITED KINGDOM;

CHILD, PRESCHOOL; CLINICAL TRIALS AS TOPIC; DIAGNOSTIC ERRORS; HUMANS; KIDNEY NEOPLASMS; MULTICENTER STUDIES AS TOPIC; NEOPLASM STAGING; OBSERVER VARIATION; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); PATHOLOGY, CLINICAL; PEER REVIEW; RETROSPECTIVE STUDIES; WILMS TUMOR;

EID: 65649096187     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.24214     Document Type: Article

References (20)

1. Graf N. Tournade M-F, de Kraker J. The role of preoperative chemotherapy in the management of Wilms tumor. Urol Clin North Am. 2000;27:443-454.
2. Neville H. L. Ritchey ML. Wilms tumor. Overview of National Wilms Tumor Study Group results. Urol Clin North Am. 2000;27:435-442.
3. Tournade M. F. Com-Nouge C, de Krajer J. et al. Results of the Sixth International Society of Pediatric Oncology Wilms' Tumor Trial and Study: a risk adapted therapeutic approach in Wilms' tumor. J Clin Oncol. 1993; 11:1014-1023. (Pubitemid 23163339)
4. De Kraker J. Delemarre J. F. M. Lilien M. R. Tournade M-F. Misstaging in nephroblastoma. Causes and Consequences. A report of the sixth nephroblastoma trial and study of the International Society of Paediatric Oncology. Eur J Pediatr Surg. 1999;9:153-157. (Pubitemid 29329904)
5. Tournade M. F. Com-Nougue C, de Kraker J. et al. Optimal duration of preoperative therapy in unilateral and non-metastatic Wilms' tumour in children older than 6 months: results of the Ninth International Society of Pediatric Oncology Wilms' tumour trial and study.J Clin Oncol. 2001; 19:488-500. (Pubitemid 32112863)
6. Boccon-Gibod L. Rey A. Sandstedt B. et al. Complete necrosis induced by preoperative chemotherapy in Wilms' tumor as an indicator of low risk; report of the International Society of Paediatric Oncology (SIOP) Wilms' tumor trial and study 9. Med Pediatr Oncol. 2000;34:183-190. (Pubitemid 30132140)
7. Weirich A. Leuschner I. Harms D. et al. Clinical impact of histologic subtypes in localized non-anaplastic nephroblastoma treated according to the trial and study SIOP-9 /GPOH. Ann Oncol. 2001;12:311-319. (Pubitemid 32288685)
8. De Kraker J. Graf N, van Tinteren H. et al. Reduction of postoperative chemotherapy In children with stage I intermediate-risk and anaplastic Wilms' tumour (SIOP 93-01 trial): a randomised controlled trail. Lancet. 2004;364: 1229-1235.
9. Mitchell C. Pritchard Jones K. Shannon R. et al. Immediate nephrectomy versus pre-operative chemotherapy in the management of non-metastatic Wilms' tumor: results of a randomized trial (UKWT3) by the UK Children's Cancer Study Group. Eur J Cancer. 2006;42:2554-2562. (Pubitemid 44442940)
10. SIOP 2001Nephroblastoma Trial and Study Protocol, 2001.
11. SIOP 93-01 Nephroblastoma Trial and Study Protocol, 1993.
12. Dome J. S. Cotton C. A. Perlman E. J. et al. Treatment of anaplastic Wilms' tumor: results from the fifth National Wilms' Tumor Study. J Clin Oncol. 2006;24:2352-2358. (Pubitemid 46630667)
13. Qualman S. J. Coffin C. M. Newton W. A. et al. Intergroup rhabdomyosarcoma study: update for pathologists. Pediatr Dev Pathol 1998;1:550-561. (Pubitemid 128542175)
14. Parkers S. E. Muir K. R. Cameron A. H. et al. The need for specialist review of pathology in paediatric cancer. Br J Cancer. 1997;75:1156-1159. (Pubitemid 27140027)
15. Delaney R. J. Savers C. D. Walker M. A. Mead C. M. Theaker JM. The continued value of central histopathology review of testicular tumours. Histopathology. 2005;47:166-169. (Pubitemid 41113119)
16. Scott C. B. Nelson J. S. Farnan N. C. et al. Central Pathology Review in clinical trials for patients with malignant glioma3 A report of Radiation Therapy Oncology Group 83-02. Cancer. 1995;76:307-313.
17. Van Dijk M. C. Aben KK, van Hees F. et al. Expert review remains important In the histopathological diagnosis of cutaneous melanocytic lesions. Histopathology. 2008;52:139-416.
18. Van der Kwast T. H. Collette L. Van Poppel, et al. Impact of pathology review of stage and margin status of radical prostatectomy specimens (EORTC trial 22911). Virchows Arch. 2006;449:428-434. (Pubitemid 44451317)
19. Furness P. Guidelines on Inter-departmental Dispatch of Samples From Patients Sent to Another Hospital or Centre for Assessment and/or Treatment. 2nd ed. London, UK: The Royal College of Pathologists; 2006.
20. Teot L. A. Sposto R. Khayat A. Qualman S. Reaman G. Parham D. The problems and promise of central pathology review: development of a standardized procedure for the Children's Oncology Group. Pediatr Dev Pathol. 2007;10: 199-207. (Pubitemid 350188038)